Prosperity Wealth Management »

Global X Fds genomic biotech shares owned by Prosperity Wealth Management

Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Prosperity Wealth Management from 13F filings

Historical chart of Prosperity Wealth Management investment in Global X Fds genomic biotech

Tip: Access up to 7 years of quarterly data

All positions including Global X Fds genomic biotech held by Prosperity Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Global X Fds genomic biotech by Prosperity Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $544k 47k 11.56

More positions owned by Prosperity Wealth Management

Proshares Tr Ultrapro Qqq (TQQQ)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Proshares Tr Ultrpro S&p500 (UPRO)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Strategy Day Hagan Ned (SSUS)
Invesco Exch Trd Slf Idx Rafi Stratgic Us (IUS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Procter & Gamble Company (PG)
Wynn Resorts (WYNN)
Select Sector Spdr Tr Technology (XLK)

View all positions for Prosperity Wealth Management

Top funds holding Global X Fds genomic biotech

Jane Street
One Capital Management
Mirae Asset Global Investments
Lido Advisors
Raymond James Financial Services Advisors
Portland Global Advisors
UBS Group
Stratos Wealth Partners
Sightline Wealth Advisors
Oppenheimer Asset Management
McGuire Investment Group
Berson & Corrado Investment Advisors
LPL Financial
Prosperity Wealth Management
Manhattan West Asset Management

View all funds holding Global X Fds genomic biotech